Skip to Content
myAACR
Donate Today

Progress Against Cancer

Home » Patients, Caregivers, and Advocates » Progress Against Cancer » Progress Against Cancer

Recent Progress: FDA Approvals

Targeting Multiple Myeloma

Targeting Multiple Myeloma

The FDA approved the molecularly targeted therapeutic selinexor to be used in combination with another targeted agent and a synthetic corticosteroid to treat certain patients with multiple myeloma. The U.S. Food and Drug Administration...